Background Cost-effectiveness studies inform resource allocation, strategy, and policy
development. However, due to their complexity, dependence on assumptions made, and …

What do we know about the cost–effectiveness of HIV preexpos... : Current Opinion in HIV and
AIDS What do we know about the cost–effectiveness of HIV preexposure prophylaxis, and is it …

Future cost effectiveness studies should consider PrEP implementation issues (uptake in
high-risk versus low-risk groups, duration on PrEP, adherence), budget impact, and the role …

Background Approaches that allow easy access to pre-exposure prophylaxis (PrEP), such
as over-the-counter provision at pharmacies, could facilitate risk-informed PrEP use and …

Background Mathematical modelers have given little attention to the question of how pre-
exposure prophylaxis (PrEP) may impact on a generalized national HIV epidemic and its …

Summary Background Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine
prevents HIV infections among men who have sex with men (MSM). PrEP can be given on a …

Background. Recent trials report the short-term efficacy of tenofovir-based pre-exposure
prophylaxis (PrEP) for prevention of human immunodeficiency virus (HIV) infection. PrEP's …

Background Antiretroviral therapy (ART) and oral pre-exposure prophylaxis (PrEP) are
effective in reducing HIV transmission in heterosexual adults. The epidemiologic impact and …

Abstract Background. For young South African women at risk for human immunodeficiency
virus (HIV) infection, preexposure prophylaxis (PrEP) is one of the few effective prevention …

Objective: To compare the value and effectiveness of different prioritization strategies of pre-
exposure prophylaxis (PrEP) in New York City (NYC). Design: Mathematical modelling …